普洛药业 (000739)

Apeloa Pharmaceutical Co.,Ltd.

ASZ

Tags

Contract Research Organization (CXO)Shanghai Free Trade ZoneElderly Care ConceptPension FundsWeight Loss DrugsInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingSynthetic BiologyBuyback PlansGuozheng Value IndexPet EconomySmall Cap ValueIndustrial InternetNuclear Pollution Prevention and ControlHigh-Performing StocksMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 115844.36
  • Circulating A-Shares(W): 115800.84
  • Earnings Per Share(RMB): 0.6063
  • Net Assets Per Share(RMB): 5.5992
  • Operating Revenue(W RMB): 776388.21
  • Total Profit(W RMB): 83913.95
  • Net Profit Attributable to Parent(W RMB): 70026.61
  • Net Profit Growth Rate(%): -19.48
  • Weighted Return on Equity(%): 10.21
  • Operating Cash Flow Per Share(RMB): 0.6680
  • Undistributed Profit Per Share(RMB): 4.2953
  • Capital Reserve Per Share(RMB): 0.0905

2. Main Business

The main business covers:

  • Active Pharmaceutical Ingredients (API) Intermediates
  • Innovative Drug R&D and Production Services (CDMO)
  • R&D, Production, and Sales of Drugs
  • Import and Export Trade Business

3. Company Basic Information

  • Company Name: Apeloa Pharmaceutical Co., Ltd.
  • Listing Date: 1997-05-09
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 399 Jiangnan Road, Hengdian Town, Dongyang City, Zhejiang Province, China
  • Website: www.apeloa.com
  • Company Profile: The company's predecessor was Qingdao Oriental Trade Building. In 1996, it underwent a shareholding system reform, converting its operating net assets into 32.6 million state shares, 400,000 private placement legal person shares, and 3 million internal employee shares. After the public offering in April 1997, the total share capital at the time of listing reached 63 million shares. The employee shares were scheduled to be listed six months after the 27 million public shares were listed on May 9, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hengdian Group Holding Co., Ltd. General Legal Person 33094.17 28.58
2 Zhejiang Hengdian Import & Export Co., Ltd. General Legal Person 15655.29 13.52
3 Zhejiang Hengrun Technology Co., Ltd. General Legal Person 5968.38 5.15
4 Hengdian Group Jiayuan Chemical Co., Ltd. General Legal Person 4475.02 3.86
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3499.97 3.02
6 Apeloa Pharmaceutical Co., Ltd. - Phase I Employee Stock Ownership Plan General Legal Person 2156.40 1.86
7 Dacheng Ruixiang Hybrid Securities Investment Fund Class A Fund 1874.82 1.62
8 Dacheng Gaoxin Equity Securities Investment Fund Class A Fund 1306.42 1.13
9 Dacheng Competitive Advantage Hybrid Securities Investment Fund Class A Fund 1187.07 1.03
10 Qianhai Life Insurance Co., Ltd. - Dividend Insurance Product Insurance 1002.50 0.87

5. Concept Sectors

  • Shanghai Free Trade Zone
  • Aging Care Concept
  • Industrial Internet
  • Medical Aesthetics Concept
  • CXO Concept
  • Nuclear Pollution Control
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • Pet Economy
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Share Buyback Plan
  • Pension Fund Holdings
  • Small Cap Value
  • SZSE Value Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information